Alembic Ltd.
| BSE: 506235 | Sector: Health care |
| NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
| BSE 16:01 | 30 Jan | 67.25 |
-1.50 (-2.18%) |
OPEN
65.05 |
HIGH
68.50 |
LOW
65.05 |
| NSE 15:48 | 30 Jan | 67.15 |
-1.45 (-2.11%) |
OPEN
68.20 |
HIGH
68.55 |
LOW
67.00 |
| OPEN | 65.05 |
| PREVIOUS CLOSE | 68.75 |
| VOLUME | 15724 |
| 52-Week high | 102.85 |
| 52-Week low | 56.50 |
| P/E | 23.60 |
| Mkt Cap.(Rs cr) | 1,727 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alembic Ltd. (ALEMBICLTD) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 1050.90 | 7.30 | 0.70 | 15585.98 |
| Dr Reddy's Labs | 4331.45 | 13.15 | 0.30 | 14405.20 |
| Cipla | 1037.50 | -9.55 | -0.91 | 13091.79 |
| Lupin | 732.25 | -9.95 | -1.34 | 11771.67 |
| Aurobindo Pharma | 411.60 | -4.65 | -1.12 | 11287.14 |
| Divi's Lab. | 3369.35 | -16.20 | -0.48 | 8879.82 |
| Alkem Lab | 3004.50 | 6.90 | 0.23 | 8829.81 |
| Glenmark Pharma. | 371.10 | -10.30 | -2.70 | 8141.58 |
| Zydus Lifesci. | 427.75 | -2.50 | -0.58 | 7981.90 |
| Torrent Pharma. | 1545.05 | 7.25 | 0.47 | 6742.32 |
| Apollo Hospitals | 4249.00 | 5.70 | 0.13 | 6098.30 |
| Ipca Labs. | 854.00 | 3.40 | 0.40 | 5399.36 |
| Alembic Pharma | 535.75 | -2.35 | -0.44 | 5035.41 |
| Abbott India | 20967.75 | -252.10 | -1.19 | 4919.27 |
| Laurus Labs | 341.85 | 0.00 | 0.00 | 4707.04 |
| Gland Pharma | 1311.90 | -45.20 | -3.33 | 4400.71 |
| Granules India | 291.25 | 7.15 | 2.52 | 3238.44 |
| Glaxosmi. Pharma | 1257.00 | -4.60 | -0.36 | 3217.51 |
| Ajanta Pharma | 1209.25 | 27.40 | 2.32 | 3140.64 |
| Piramal Pharma | 101.95 | -0.95 | -0.92 | 3094.95 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
